Fine-Tuning a Transformer Model for METTL3 Lead Optimization
Transformers are machine learning models originally developed to translate between natural languages. Recently, a transformer model was trained on knowledge of medicinal chemistry, i.e., matched molecular pairs of nearly a million bioactive compounds from the ChEMBL database. Here, we customize (i.e., fine-tune) the pretrained model to enhance the affinity and/or metabolic stability of a series of inhibitors of methyltransferase-like protein 3 (METTL3). We first fine-tune the transformer model using a data set of about 500 METTL3 inhibitors with known binding affinities and validate it by retrospective analysis. Then, we fine-tune the original transformer model to simultaneously optimize binding affinity and metabolic stability in a prospective application. Two of the five METTL3 inhibitors predicted by the multiobjective optimized model show low-nanomolar potency and higher stability than the lead compound of the chemical series used for fine-tuning.
Authors
- Amedeo Caflisch (ORCID: https://orcid.org/0000-0002-2317-6792)
- Christian M Matter (ORCID: https://orcid.org/0000-0002-2659-3137)
Publication Details
- Journal
- Universität Zürich, ZORA
- Published
- 2026-04-15
- DOI
- https://doi.org/10.5167/uzh-433755
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00